IL13RA2 targeted alpha particle therapy against glioblastomas

Glioblastoma (GBM) is the most aggressive primary malignant brain cancer that invariably results in a dismal prognosis. Chemotherapy and radiotherapy have not been completely effective as standard treatment options for patients due to recurrent disease. We and others have therefore developed molecul...

Descripción completa

Detalles Bibliográficos
Autores principales: Sattiraju, Anirudh, Sai, Kiran Kumar Solingapuram, Xuan, Ang, Pandya, Darpan N., Almaguel, Frankis G., Wadas, Thaddeus J., Herpai, Denise M., Debinski, Waldemar, Mintz, Akiva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522122/
https://www.ncbi.nlm.nih.gov/pubmed/28562337
http://dx.doi.org/10.18632/oncotarget.17792

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522122/
https://www.ncbi.nlm.nih.gov/pubmed/28562337
http://dx.doi.org/10.18632/oncotarget.17792

Ejemplares similares